![George Morstyn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
George Morstyn
Direktor/Vorstandsmitglied bei
ACTINOGEN MEDICAL LIMITED
Vermögen: 477 451 $ am 31.05.2026
Profil
George Morstyn is currently Chief Executive Officer at G & R Morstyn Pty Ltd. since 2006.
Current roles also include Independent Director at Oncology One Pty Ltd., Non-Executive Director at Actinogen Medical Ltd. since 2017, Outside Director at SymBio Pharmaceuticals Ltd., Investment Committee Member at GBS Venture Partners Pty Ltd., and Member of the Australian Institute of Co. Directors.
Former positions include Director at Proacta, Inc., Independent Non-Executive Director at ChemGenex Pharmaceuticals Pty Ltd. in 2011, Director at Bionomics Ltd., Non-Executive Director at ChemGenex Pharmaceuticals, Inc., Director at SymBio Pharmaceuticals Ltd. from 2003 to 2019, Director-Supervisory Board at Amsterdam Molecular Therapeutics (AMT) Holding NV, Director at Glykoz Pharma Discovery Pty Ltd., Director at Cancer Trials Australia, Director at Victorian Comprehensive Cancer Centre Pty Ltd., Chief Medical Officer & Senior VP-Development at Amgen, Inc. from 1991 to 2002, and Head-Clinical Program at Ludwig Institute for Cancer Research Ltd. from 1983 to 1991.
Education includes undergraduate studies at Monash University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.03.2026 | 17 463 454 ( 0,48 % ) | 477 451 $ | 31.05.2026 |
Aktive Positionen von George Morstyn
| Unternehmen | Position | Beginn |
|---|---|---|
| ACTINOGEN MEDICAL LIMITED | Direktor/Vorstandsmitglied | 01.12.2017 |
| SYMBIO PHARMACEUTICALS LIMITED | Direktor/Vorstandsmitglied | - |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
GBS Venture Partners Pty Ltd.
 GBS Venture Partners Pty Ltd. Investment ManagersFinance GBS Venture Partner seeks investment opportunities in private and public companies located in the United States, New Zealand and primarily in Australia. The firm targets companies operating in the fields of human healthcare, biotechnology, life science, biological/small molecule therapeutics, medical devices and diagnostics. It provides financing for seed, early and later stage capital requirements with an investment size ranging from of USD 10 to 12 million. It takes an active role on the board of directors and acts as a lead investor. It also makes co-investments. | Mitglied des Investmentausschusses | - |
G & R Morstyn Pty Ltd. | Vorstandsvorsitzender | 01.04.2006 |
Oncology One Pty Ltd.
 Oncology One Pty Ltd. BiotechnologyHealth Technology Develops novel oncology drug and clinical diseases for cancer | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von George Morstyn
| Unternehmen | Position | Ende |
|---|---|---|
| SYMBIO PHARMACEUTICALS LIMITED | Direktor/Vorstandsmitglied | 01.01.2019 |
ChemGenex Pharmaceuticals Pty Ltd.
 ChemGenex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direktor/Vorstandsmitglied | 07.06.2011 |
Amsterdam Molecular Therapeutics (AMT) Holding NV
 Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Specializes in human gene therapy for metabolic disorders and ocular diseases | Corporate Officer/Principal | 20.09.2010 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von George Morstyn
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Proacta, Inc.
 Proacta, Inc. BiotechnologyHealth Technology Develops drugs to treat cancer | Health Technology |
Oncology One Pty Ltd.
Oncology One Pty Ltd. BiotechnologyHealth Technology Develops novel oncology drug and clinical diseases for cancer | Health Technology |
ChemGenex Pharmaceuticals Pty Ltd.
ChemGenex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Bionomics Ltd.
 Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Health Technology |
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ChemGenex Pharmaceuticals, Inc.
 ChemGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceuticals | Health Technology |
GBS Venture Partners Pty Ltd.
GBS Venture Partners Pty Ltd. Investment ManagersFinance GBS Venture Partner seeks investment opportunities in private and public companies located in the United States, New Zealand and primarily in Australia. The firm targets companies operating in the fields of human healthcare, biotechnology, life science, biological/small molecule therapeutics, medical devices and diagnostics. It provides financing for seed, early and later stage capital requirements with an investment size ranging from of USD 10 to 12 million. It takes an active role on the board of directors and acts as a lead investor. It also makes co-investments. | Finance |
Amsterdam Molecular Therapeutics (AMT) Holding NV
Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Specializes in human gene therapy for metabolic disorders and ocular diseases | Commercial Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Actinogen Medical Ltd.
 Actinogen Medical Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and develops biotechnology compounds | Health Technology |
Ludwig Institute for Cancer Research Ltd.
 Ludwig Institute for Cancer Research Ltd. Medical/Nursing ServicesHealth Services Engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials | Health Services |
SymBio Pharmaceuticals Ltd.
 SymBio Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutics for cancer and other related diseases | Health Technology |
Glykoz Pharma Discovery Pty Ltd.
 Glykoz Pharma Discovery Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops carbohydrate based drugs | Health Technology |
Cancer Trials Australia | |
Victorian Comprehensive Cancer Centre Pty Ltd.
 Victorian Comprehensive Cancer Centre Pty Ltd. BiotechnologyHealth Technology Provides cancer research and clinical care facilities | Health Technology |
G & R Morstyn Pty Ltd. |
